Why Did Indaptus Plunge 24.44%? Reverse Split, Private Placement
Before the BellWednesday, Jun 25, 2025 7:12 am ET
1min readOn June 25, 2025,
experienced a significant drop of 24.44% in pre-market trading, marking a notable decline in its stock performance.Indaptus Therapeutics has announced a reverse stock split, effective from June 27, 2025. This move aims to increase the company's per-share price to meet Nasdaq's continued listing requirements and potentially attract more investors. The common stock will trade on the Nasdaq Capital Market under a new CUSIP number, 45339J 204, following the split.
Indaptus Therapeutics has also completed a private placement of convertible notes and warrants, raising $2.3 million. This financial maneuver is part of the company's strategy to bolster its liquidity and support ongoing operations and development efforts.
Disclaimer: The news articles available on this platform are generated in whole or in part by artificial intelligence and may not have been reviewed or fact checked by human editors. While we make reasonable efforts to ensure the quality and accuracy of the content, we make no representations or warranties, express or implied, as to the truthfulness, reliability, completeness, or timeliness of any information provided. It is your sole responsibility to independently verify any facts, statements, or claims prior to acting upon them. Ainvest Fintech Inc expressly disclaims all liability for any loss, damage, or harm arising from the use of or reliance on AI-generated content, including but not limited to direct, indirect, incidental, or consequential damages.
Comments
No comments yet